Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IKNA

Ikena Oncology (IKNA)

Ikena Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IKNA
DateTimeSourceHeadlineSymbolCompany
11/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
29/05/202406:42GlobeNewswire Inc.UPDATE – Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
29/05/202406:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
29/05/202406:15GlobeNewswire Inc.Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
14/05/202406:45GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
14/05/202406:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
10/04/202422:00GlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
12/03/202423:00GlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
06/03/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
06/03/202408:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
28/02/202400:00GlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
22/02/202408:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
22/02/202408:15GlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
03/02/202409:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
03/02/202409:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
19/01/202408:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
19/01/202408:05GlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
09/11/202323:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
09/11/202323:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
09/11/202323:00GlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
08/11/202300:00GlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
12/10/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
26/09/202306:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
16/09/202306:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
13/09/202306:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
11/09/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
05/09/202322:00GlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
19/08/202306:03Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
19/08/202306:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
10/08/202322:00GlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:IKNA